Marco Gerlinger
@MarcoGerlinger
Followers
1K
Following
90
Statuses
376
Medical Oncologist and Clinician Scientist working on GI Cancer Genomics/Cancer Evolution, Immunotherapies and Biomarkers
London, England
Joined November 2014
Still time to register for our free @AACR IO webinar today: “Tumour Mutation Burden, Heterogeneity and Immunotherapy Efficacy”with Profs Jaffe, Quezada and Wargo
0
5
5
Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in @trendscancer
2
16
43
Touched down in Miami for the 2024 @CCAlliance #CureCRC Summit - very exciting to be here again to help make this cancer history. Well prepared after lovely Christmas dinner and afternoon tea (‼️‼️) on board of the A380 💪💪💪
0
2
4
RT @DrHongchengZhu: Starting from International Exchange Award between UK and China supported by @royalsociety, more exciting opportunities…
0
1
0
RT @BartsGI_Cancer: Kickoff meeting of our new St Barts Hospital - Fudan University Cancer Centre Oesophageal Cancer Research Collaboration…
0
1
0
Outstanding session with @elena_elez and @BenjcRousseau on immunotherapy biomarkers at @ASCO #ASCO24 this morning. Key messages: Exciting and powerful new IO biomarkers on the horizon. We now need to apply them to large clinical trials including those from industry.
0
3
12
Great talk on chromosomal instability by my @QMBCI colleague Dr McClelland @McclellandLab at #AACR24 @AACR in RM29 ongoing
1
4
27
RT @YaleCancer: .@politikaterina will be presenting during the Lineage Plasticity in Tumor Evolution and Acquired Resistance educational se…
0
6
0
RT @CharlesSwanton: What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architectu…
0
165
0
RT @YaleCancer: .@JeffTownsend discussed how the evolution of #cancer is rarely linear, but a branching model that influences progression #…
0
2
0
Looking forward to meet for a drink (and science discussion of course…)
0
0
0
Important POSTER SESSIONS For those of you at #AACR24: 👉🏻Tumor Evolution in Space and Time is on Monday 9am-12:30 (section 12) 👉🏻Tumor Evolution Models and Technologies on Tuesday 9am-12:30 (section 13) We received 🏅outstanding 🥇 abstracts this year. Don‘t miss out!!
0
1
7
RT @MyriamChalabi: What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess @NatureMedicin…
0
65
0
RT @QMBCI: We're delighted that Prof Tom Powles (@tompowles1) has been selected as one of @Nature's 10 people who shaped science for his tr…
0
4
0
It’s a great honour to be part of the @CCAlliance inaugural #CureCRCsummit this week. Brainstorming strategies to cure #colorectal cancer with giants in the field Drs @skopetz, Batlle, Venook, Lenz, @MyriamChalabi, @AndreaCercek + many others
0
3
9
RT @BartsGI_Cancer: Important point made in an article in @guardian today: better outcomes for cancer patients who are treated in research…
0
2
0
-Parallel evolution which surpasses even that in RCC! -Big headache for biomarker development! Our study on ITH in dMMR CRCs is out: High mutation supply and strong immune selection pressures make this a great model tumor for #CancerEvo studies
0
4
22
@BartsGI_Cancer @tompowles1 An absolutely amazing result that transforms bladder cancer management. Congratulations Tom!
0
0
2
RT @BartsGI_Cancer: #ESMO23 congress starts tomorrow. @BartsGI_Cancer consultants @rillepihlak and @MarcoGerlinger will be there and tweet…
0
1
0
“Understanding immune evasion and suppression in colon cancer liver mets through single cell sequencing” Exciting PhD opportunity in my lab at the Barts Cancer Institute: check details and apply here:
0
10
16